Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor

Hepatology

Volumn 50, Issue 3, 2009, Pages 799-807

  Hoechst, Bastian ^a,b   Voigtlaender, Torsten ^a,b   Ormandy, Lars ^a,c   Gamrekelashvili, Jaba ^a,b   Zhao, Fei ^a,b   Wedemeyer, Heiner ^a   Lehner, Frank ^a   Manns, Michael P ^a   Greten, Tim F ^a,b   Korangy, Firouzeh ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; CELL RECEPTOR; GAMMA INTERFERON; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN NKP30 RECEPTOR; STAT PROTEIN; UNCLASSIFIED DRUG; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3;

AGED; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; LIVER CELL CARCINOMA; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SUPPRESSOR CELL; CD4+ T LYMPHOCYTE; IMMUNOLOGY; LIVER TUMOR; PHYSIOLOGY;

AGED; CARCINOMA, HEPATOCELLULAR; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MALE; MYELOID CELLS; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3;

EID: 70349240416     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23054     Document Type: Article

References (26)

1. Serafini P, Borrello I, Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 2006;16:53-65. (Pubitemid 43139709)
2. Pak AS, Wright MA, Matthews JP, Collins SL, Petruzzelli GJ, Young MR. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin Cancer Res 1995;1:95-103.
3. Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005;65:3044-3048. (Pubitemid 40524582)
4. Mirza N, Fishman M, Fricke I, Dunn M, Neuger AM, Frost TJ, et al. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res 2006;66:9299-9307. (Pubitemid 44521152)
5. Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001;166:678-689. (Pubitemid 32038493)
6. Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, et al. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res 2004;10: 4332-4341. (Pubitemid 38878871)
7. Ormandy LA, Farber A, Cantz T, Petrykowska S, Wedemeyer H, Horning M, et al. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J Gastroenterol 2006;12:3275-3282. (Pubitemid 43881355)
8. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, Manns MP, et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008;135:234-243. (Pubitemid 351899008)
9. Caligiuri MA. Human natural killer cells. Blood 2008;112:461-469.
10. Carrega P, Morandi B, Costa R, Frumento G, Forte G, Altavilla G, et al. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. Cancer 2008;112:863-875. (Pubitemid 351240580)
11. Fauriat C, Moretta A, Olive D, Costello RT. Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients. Blood 2005;106:2186-2188. (Pubitemid 41291738)
12. Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, et al. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 2005;43:1013-1020. (Pubitemid 41627987)
13. Cai L, Zhang Z, Zhou L, Wang H, Fu J, Zhang S, et al. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. Clin Immunol 2008;129:428-437.
14. Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumorbearing host. Blood 2007;109:4336-4342. (Pubitemid 46743401)
15. Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 1999;5:444-447. (Pubitemid 29180586)
16. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-998. (Pubitemid 35363648)
17. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004;21:137-148.
18. Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005;65:2457-2464. (Pubitemid 40490158)
19. Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 2007;7:329-339. (Pubitemid 46674487)
20. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002;195:335-341. (Pubitemid 34461491)
21. Ghiringhelli F, Menard C, Terme M, Flament C, Taieb J, Chaput N, et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 2005; 202:1075-1085.
22. Chuang WL, Liu HW, Chang WY, Chen SC, Hsieh MY, Wang LY. Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage. Dig Dis Sci 1991;36:299-302.
23. Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008;222:162-179.
24. Nausch N, Galani IE, Schlecker E, Cerwenka A. Mononuclear myeloidderived "suppressor" cells express RAE-1 and activate NK cells. Blood 2008;112:4080-4089.
25. Li H, Han Y, Guo Q, Zhang M, Cao X. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol 2009;182:240-249.
26. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002;195:343-351. (Pubitemid 34461492)